(Q34496453)

2 August 2017

1 reference

title

The role of cardiac metaiodobenzylguanidine uptake in the differential diagnosis of parkinsonian syndromes (English)

1 reference

2 August 2017

1 reference

Braune S

1

1 reference

2 August 2017

1 December 2001

1 reference

Clinical Autonomic Research

2 August 2017

1 reference

2 August 2017

11

1 reference

2 August 2017

6

1 reference

2 August 2017

351-355

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02292766

2 August 2017

0 references

cites work

Scintigraphic assessment of regional cardiac adrenergic innervation

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02292766

Cardiac uptake of [123I]MIBG separates Parkinson's disease from multiple system atrophy

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FBF02292766

[123I-MIBG myocardial scintigraphical analysis in patients with and without autonomic disorder]

21 January 2018

1 reference

12 December 2020

Decreased myocardial 123I-MIBG uptake in Parkinson's disease

1 reference

12 December 2020

Impaired cardiac uptake of meta-[123I]iodobenzylguanidine in Parkinson's disease with autonomic failure

1 reference

12 December 2020

Complementary PET studies of striatal neuronal function in the differential diagnosis between multiple system atrophy and Parkinson's disease.

1 reference

12 December 2020

Radiolabelled meta-iodobenzylguanidine in assessment of autonomic dysfunction

1 reference

12 December 2020

(123)I-metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease

1 reference

12 December 2020

Cardiac sympathetic denervation in Parkinson disease

1 reference

12 December 2020

Metaiodobenzylguanidine imaging in diabetes mellitus: Assessment of cardiac sympathetic denervation and its relation to autonomic dysfunction and silent myocardial ischemia

1 reference

12 December 2020

Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man

1 reference

12 December 2020

A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG)

1 reference

12 December 2020

1 reference

12 December 2020

Radioiodinated metaiodobenzylguanidine: a review of its biodistribution and pharmacokinetics, drug interactions, cytotoxicity and dosimetry

1 reference

12 December 2020

1 reference

12 December 2020

Differentiation of idiopathic Parkinson's disease from striatonigral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy

1 reference

12 December 2020

Scintigraphic detection of regional disruption of adrenergic neurons in the heart

1 reference

12 December 2020

Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG.

1 reference

12 December 2020

Myocardial m-[123I]iodobenzylguanidine scintigraphy for the assessment of adrenergic cardiac innervation in patients with IDDM. Comparison with cardiovascular reflex tests and relationship to left ventricular function

1 reference

12 December 2020

Morphological and functional imaging studies on the diagnosis and progression of Parkinson's disease

1 reference

12 December 2020

Adrenergic supersensitivity in parkinsonians with orthostatic hypotension

1 reference

12 December 2020

Uptake of meta-iodobenzylguanidine by bovine chromaffin granule membranes

1 reference

12 December 2020

Scintigraphic evidence for cardiac sympathetic dysinnervation in long-term IDDM patients with and without ECG-based autonomic neuropathy

1 reference

12 December 2020

Adrenal medulla imaging agents: a structure-distribution relationship study of radiolabeled aralkylguanidines

1 reference

12 December 2020

Loss of 123I-MIBG uptake by the heart in Parkinson's disease: assessment of cardiac sympathetic denervation and diagnostic value

1 reference

12 December 2020

Evaluation of metaiodobenzylguanidine uptake by the norepinephrine, dopamine and serotonin transporters

1 reference

12 December 2020

Imaging the primate adrenal medulla with [123I] and [131I] meta-iodobenzylguanidine: concise communication

1 reference

12 December 2020

Sympathetic cardioneuropathy in dysautonomias

1 reference

12 December 2020

Differential diagnosis of parkinsonism with [18F]fluorodeoxyglucose and PET.

1 reference

12 December 2020

Parkinson's disease: the distribution of Lewy bodies in the peripheral autonomic nervous system

1 reference

12 December 2020

Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. taki@med.kanazawa-u.ac.jp

1 reference

12 December 2020

Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function

1 reference

12 December 2020

L-threo-dihydroxyphenylserine (L-threo-DOPS; droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-center, dose-ranging study in multiple system atrophy and pure autonomic failure

1 reference

12 December 2020

Cardiac uptake of [123I]MIBG separates PD from multiple system atrophy

1 reference

12 December 2020

Sodium dependency of uptake of norepinephrine and m-iodobenzylguanidine into cultured human pheochromocytoma cells: evidence for uptake-one

1 reference

12 December 2020

Lewy bodies in the visceral autonomic nervous system in Parkinson's disease

1 reference

12 December 2020

Differentiating Parkinson disease from multiple-system atrophy by measuring cardiac iodine-123 metaiodobenzylguanidine accumulation

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF02292766

1 reference

release_c463673f4jdx7eex7xskc3wtga

2 August 2017

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/c463673f4jdx7eex7xskc3wtga

24 November 2022

mapped directly with Wikidata item

PubMed ID

11794715

1 reference

PubMed ID

11794715